Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Recursion Pharmaceuticals Inc
RXRX
Healthcare
Biotechnology
Recursion Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States and the United Kingdom. The company develops REC-4881, which is in Phase 1b/2 clinical trial to treat familial...
adenomatous polyposis; REC-617, which is in Phase 1/2 clinical trial to treat advanced solid tumors; REC-1245, which is in Phase 1/2 clinical trial to treat biomarker-enriched solid tumors and lymphoma; REC-3565 that is in Phase 1/2 for the treatment of relapsed or refractory B-cell malignancies; and REC-4539, a reversible, CNS penetrant, orally bioavailable, and potential best-in-class inhibitor of LSD1 for the treatment of solid tumors and hematology oncology. Its preclinical stage product includes REC-7735 for the treatment of HR+ breast cancer; and REC-102 for the treatment of hypophosphatasia...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:RXRX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(88)
•••
Humanist
X
Post by
Humanist
on Apr 30, 2026 9:46pm
Recursion Announces Board Transition
Recursion Announces Board Transition by @GlobeNewswire on 30 Apr 2026, 16:30 $RXRX.US 4.85% Salt Lake City, UT
...more
(88)
•••
Humanist
X
Post by
Humanist
on Feb 23, 2026 9:11am
RXRX: Recursion WILL BE FEATURED IN HIGHRES TALK AT NVDA GTC
Recursion To Be Featured in HighRes’ Lightning Talk at NVIDIA GTC by @GlobeNewswire on 23 Feb 2026, 8:00 Join the Discussion: $RXRX.US -8.06% Salt Lake City, Feb. 23
...more
Discover Where Innovation, Technology, and Investor Opportunity Converge
posted May 12, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
From quantum advancements to emerging market shifts, the Innovation Report delivers strategic insights into high-growth sectors and breakthrough technologies shaping tomorrow’s economy and investor positioning worldwide. ...Explore Now
(44)
•••
BugTSWY
X
Post by
BugTSWY
on Feb 09, 2026 12:15am
Rec-4881
Rec-4881 trail discontinued.
(44)
•••
BugTSWY
X
Post by
BugTSWY
on Jan 26, 2026 12:21pm
Dipping the toe.
Rolling the dice. Might be a winner later this year.
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Dec 17, 2025 8:55am
Buy buddy buy.
Otherwise FOMO for you fellas out there today
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Nov 04, 2025 6:33am
Sell buddy sell.
Otherwise you guys will be going down big-time with this stock today
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Oct 15, 2025 9:16am
Buy buddy buy.
Otherwise FOMO
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jul 21, 2025 8:04am
Using technical analysis for this stock.
It is signalling a continuing uptrend for shareholders today so good luck to all of you
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 20, 2025 7:36am
Buy buddy buy.
Otherwise
(88)
•••
Humanist
X
Post by
Humanist
on Jun 06, 2025 11:58am
MIT & RXRX RELEASE NEXT GEN AI MODEL CALLED BOLTZ-2
MIT and Recursion Release Boltz-2: Next Generation AI Model to Predict Binding Affinity at Unprecedented Speed, Scale, and Accuracy GlobeNewswire · GlobeNewswire Inc. Recursion
...more
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Jun 05, 2025 9:37am
Still holding this stock.
This stock is signalling a continuing uptrend for shareholders today anyway
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 14, 2025 5:59am
Buy buddy buy.
Otherwise you guys will be missing out on this one
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Apr 11, 2025 6:35am
Buy buddy buy because it's taking off this morning.
It is signalling a big upswing for this stock today
(153)
•••
coolfooldumbguy
X
Post by
coolfooldumbguy
on Mar 31, 2025 7:57am
Sell buddy sell.
Otherwise you guys out there will be going down today big-time with this stock already
(0)
•••
PressRelease
X
Post by
PressRelease
on Mar 18, 2025 8:00am
New Press Release - Recursion Bolsters Board of Directors with Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun
Dr. Bumpus brings deep experience in scientific innovation and regulatory strategy, while Elaine Sun adds extensive leadership in life sciences finance and corporate strategy. Salt Lake City, UT, March 18, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio...
read article.
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
AI Beyond the Data Center: The Rise of Computing Everywhere
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Podcasts